Abbasi J (2020) Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals JAMA 324:928 doi:10.1001/jama.2020.159482770383 [pii]
Ableton Live Digital Audio Workstation (2020) https://wwwabletoncom/en/live/
Alimadadi A, Aryal S, Manandhar I, Munroe PB, Joe B, Cheng X (2020) Artificial intelligence and machine learning to fight COVID-19 Physiol Genomics 52:200-202 doi:10.1152/physiolgenomics.00029.2020
Alvarez-Machancoses O, Fernandez-Martinez JL (2019) Using artificial intelligence methods to speed up drug discovery Expert Opin Drug Discov 14:769-777 doi:10.1080/17460441.2019.1621284
Amino Acid Synthesizer https://playgooglecom/store/apps/details?id=comsynthaminoacidplayer
Artigas L et al. (2020) In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm PLoS One 15:e0240149 doi:10.1371/journal.pone.0240149PONE-D-20-13552 [pii]
Aynur Abdulla et al. (2020) Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention Advanced Therapeutics doi:https://doi.org/10.1002/adtp.202000034
Batra R, Chan H, Kamath G, Ramprasad R, Cherukara MJ, Sankaranarayanan S (2020) Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies J Phys Chem Lett 11:7058-7065 doi:10.1021/acs.jpclett.0c02278
Baucum M, Khojandi A, Vasudevan R (2020) Improving Deep Reinforcement Learning with Transitional Variational Autoencoders: A Healthcare Application IEEE J Biomed Health Inform PP doi:10.1109/JBHI.2020.3027443
Beck BR, Shin B, Choi Y, Park S, Kang K (2020) Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model Comput Struct Biotechnol J 18:784-790 doi:10.1016/j.csbj.2020.03.025S2001-0370(20)30049-0 [pii]
Bembenek SD (2020) Drug Repurposing and New Therapeutic Strategies for SARS-CoV-2 Disease Using a Novel Molecular Modeling-AI Hybrid Workflow ChemRxiv Preprint
Buehler MJ (2020) Nanomechanical sonification of the 2019-nCoV coronavirus spike protein through a materiomusical approach arXiv 2003.14258
Bung N, Krishnan SR, Bulusu G, A R (2020) De Novo Design of New Chemical Entities (NCEs) for SARS-CoV-2 Using Artificial Intelligence. ChemRxiv Preprint doi:doi:10.26434/chemrxiv.11998347.v2.
C-I-TASSER https://zhanglabccmbmedumichedu/C-I-TASSER/2019-nCoV/
Cantürk S, Singh A, St-Amant P, Behrmann P (2020) Machine-learning driven drug repurposing for covid-19 arXiv doi:arXiv:2006.14707v1
Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T (2018) The rise of deep learning in drug discovery Drug Discov Today 23:1241-1250 doi:S1359-6446(17)30359-8 [pii]10.1016/j.drudis.2018.01.039
Chenthamarakshan V et al. (2020) Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models. arXiv Preprint doi:arXiv:200401215.
Coronavirus disease (COVID-2019) situation reports. (2020) http://wwwwhoint/emergencies/diseases/novel- coronavirus-2019/situation-reports
Diaz O, Dalton JAR, Giraldo J (2019) Artificial Intelligence: A Novel Approach for Drug Discovery Trends Pharmacol Sci 40:550-551 doi:S0165-6147(19)30136-1 [pii]10.1016/j.tips.2019.06.005
Eyal E, Lum G, Bahar I (2015) The anisotropic network model web server at 2015 (ANM 2.0) Bioinformatics 31:1487-1489 doi:10.1093/bioinformatics/btu847btu847 [pii]
Fleming N (2018) How artificial intelligence is changing drug discovery Nature 557:S55-S57 doi:10.1038/d41586-018-05267-x10.1038/d41586-018-05267-x [pii]
Fuchs C (2020) Everyday Life and Everyday Communication in Coronavirus Capitalism. tripleC: Communication, Capitalism & Critique Journal for a Global Sustainable Information Society 18:375-399
Gao K, Nguyen DD, Chen J, Wang R, Wei GW (2020) Repositioning of 8565 Existing Drugs for COVID-19 J Phys Chem Lett 11:5373-5382 doi:10.1021/acs.jpclett.0c01579
Ge Y et al. (2020) A Data-Driven Drug Repositioning Framework Discovered a Potential Therapeutic Agent Targeting COVID-19. bioRxiv preprint doi:https://doi.org/10.1101/2020.03.11.986836
Griffiths RR, Hernandez-Lobato JM (2020) Constrained Bayesian optimization for automatic chemical design using variational autoencoders Chem Sci 11:577-586 doi:10.1039/c9sc04026ac9sc04026a [pii]
Gysi DM et al. (2020) Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19 arXiv doi:arXiv:2004.07229v1 [pii] 2004.07229 [pii]
Heo L, Feig M (2020) Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Proteins by Machine Learning and Physics-Based Refinement bioRxiv doi:2020.03.25.008904 [pii] 10.1101/2020.03.25.008904
Hervey M (2020) Harnessing AI in drug discovery without losing patent protection Drug Discov Today doi:S1359-6446(20)30114-8 [pii] 10.1016/j.drudis.2020.03.007
Hofmarcher M et al. (2020) Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks arXiv doi:arXiv:2004.00979
Hong L, Lin J, Tao J, J. Z (2019) BERE: An Accurate Distantly Supervised Biomedical Entity Relation Extraction Network. arXiv preprint doi:arXiv:190606916 https://www.dimensions.ai/ (Accessed on 01 September 2020.)
Hu F, Jiang J, P. Y (2020) Prediction of Potential Commercially Inhibitors against SARS-CoV-2 by Multi-Task Deep Model. arXiv preprint doi:arXiv:200300728.
Huang K, Fu T, Glass L, Zitnik M, Xiao C, Sun J (2020) DeepPurpose: a deep learning library for drug-target interaction prediction and applications to repurposing and screening. ArXiv doi:arXiv:2004.08919v2
Jorba G et al. (2020) In-silico simulated prototype-patients using TPMS technology to study a potential adverse effect of sacubitril and valsartan PLoS One 15:e0228926 doi:10.1371/journal.pone.0228926 PONE-D-19-21700 [pii]
Jumper J, Tunyasuvunakool K, Kohli P, Hassabis D, team. atA (2020) Computational predictions of protein structures associated with COVID-19. DeepMind website https://deepmind.com/research/open-source/computational-predictions-of-protein-structures-associated-with-COVID-19.
Ke YY et al. (2020) Artificial intelligence approach fighting COVID-19 with repurposing drugs Biomed J doi:10.1016/j.bj.2020.05.001 S2319-4170(20)30049-4 [pii]
Keshavarzi Arshadi A et al. (2020) Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development. Front Artif Intell 3 doi:doi: 10.3389/frai.2020.00065
Kowalewski J, Ray A (2020) Predicting novel drugs for SARS-CoV-2 using machine learning from a >10 million chemical space Heliyon 6:e04639 doi:10.1016/j.heliyon.2020.e04639 S2405-8440(20)31483-3 [pii] e04639 [pii]
Lan L et al. (2020) Generative Adversarial Networks and Its Applications in Biomedical Informatics Front Public Health 8:164 doi:10.3389/fpubh.2020.00164
Lavecchia A (2019) Deep learning in drug discovery: opportunities, challenges and future prospects Drug Discov Today 24:2017-2032 doi:S1359-6446(19)30282-X [pii] 10.1016/j.drudis.2019.07.006
Li Y, Zhang C, Bell EW, Yu DJ, Zhang Y (2019) Ensembling multiple raw coevolutionary features with deep residual neural networks for contact-map prediction in CASP13 Proteins 87:1082-1091 doi:10.1002/prot.25798
Liberati A et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6:e1000100 doi:10.1371/journal.pmed.1000100
Mahapatra S, Nath P, Chatterjee M, Das N, Kalita D, Roy P, Satapathi S (2020) Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking medRxiv doi:https://doi.org/10.1101/2020.04.05.20054254
Masters PS (2006) The molecular biology of coronaviruses Adv Virus Res 66:193-292 doi:S0065-3527(06)66005-3 [pii] 10.1016/S0065-3527(06)66005-3
Mei X et al. (2020) Artificial intelligence-enabled rapid diagnosis of patients with COVID-19 Nat Med doi:10.1038/s41591-020-0931-3 10.1038/s41591-020-0931-3 [pii]
Nguyen DD, Gao K, Chen J, Wang R, Wei GW (2020) Potentially highly potent drugs for 2019-nCoV bioRxiv doi:2020.02.05.936013 [pii] 10.1101/2020.02.05.936013
Nguyen TT (2020) Artificial intelligence in the battle against coronavirus (COVID-19): a survey and future research directions. Preprint doi:DOI: 10.13140/RG.2.2.36491.23846.
Prasad K et al. (2020) Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective Int J Biol Macromol 163:1-8 doi:S0141-8130(20)33683-7 [pii] 10.1016/j.ijbiomac.2020.06.228
Qin Z, Buehler MJ (2019) Analysis of the vibrational and sound spectrum of over 100,000 protein structures and application in sonification . Extrem Mech Lett 100460 doi:https://doi.org/10.1016/j.eml.2019.100460.
Redka DS, MacKinnon SS, Landon M, Windemuth A, Kurji N, Shahani V (2020) PolypharmDB, a Deep Learning-Based Resource, Quickly Identifies Repurposed Drug Candidates for COVID-19. ChemRxiv Preprint doi:10.26434/chemrxiv.12071271.v1
Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease Lancet 395:e30-e31 doi:S0140-6736(20)30304-4 [pii] 10.1016/S0140-6736(20)30304-4
Sellwood MA, Ahmed M, Segler MH, Brown N (2018) Artificial intelligence in drug discovery Future Med Chem 10:2025-2028 doi:10.4155/fmc-2018-0212
Senior AW et al. (2019) Protein structure prediction using multiple deep neural networks in the 13th Critical Assessment of Protein Structure Prediction (CASP13) Proteins 87:1141-1148 doi:10.1002/prot.25834
Senior AW et al. (2020) Improved protein structure prediction using potentials from deep learning Nature 577:706-710 doi:10.1038/s41586-019-1923-7 10.1038/s41586-019-1923-7 [pii]
Serena H. Chen, M. Todd Young, John Gounley, Christopher Stanley, Bhowmik aD (2020) Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets bioRxiv doi:https://doi.org/10.1101/2020.04.17.047548
Smith M, Smith JC (2020) Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface ChemRxiv Preprint
SoundCloud.com https://soundcloud.com/user-275864738/viral-counterpoint-of-the-coronavirus-spike-protein-2019-ncov?in=user-275864738/sets/protein-counterpoint
Tang B, He F, Liu D, Fang M, Wu Z, Xu D (2020) AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2 bioRxiv doi:2020.03.03.972133 [pii] 10.1101/2020.03.03.972133
Ton AT, Gentile F, Hsing M, Ban F, Cherkasov A (2020) Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds Mol Inform doi:10.1002/minf.202000028
Wang M et al. (2019) Deep Graph Library: Towards Efficient and Scalable Deep Learning on Graphs. ArXiv doi:arXiv:1909.01315
Wynants L et al. (2020) Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal BMJ 369:m1328 doi:10.1136/bmj.m1328
Yang J, Anishchenko I, Park H, Peng Z, Ovchinnikov S, Baker D (2020) Improved protein structure prediction using predicted interresidue orientations Proc Natl Acad Sci U S A 117:1496-1503 doi:10.1073/pnas.1914677117 1914677117 [pii]
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER Suite: protein structure and function prediction Nat Methods 12:7-8 doi:10.1038/nmeth.3213 nmeth.3213 [pii]
Yang X, Wang Y, Byrne R, Schneider G, Yang S (2019) Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery Chem Rev 119:10520-10594 doi:10.1021/acs.chemrev.8b00728
Zeng X et al. (2020) Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning J Proteome Res doi:10.1021/acs.jproteome.0c00316
Zhang C, Zheng W, Huang X, Bell EW, Zhou X, Zhang Y (2020a) Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1 J Proteome Res 19:1351-1360 doi:10.1021/acs.jproteome.0c00129
Zhang H et al. (2020b) Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov Interdiscip Sci doi:10.1007/s12539-020-00376-6 10.1007/s12539-020-00376-6 [pii]
Zhang lab https://zhanglabccmbmedumichedu/COVID-19/
Zhang Y, Lu Z (2019) Exploring semi-supervised variational autoencoders for biomedical relation extraction Methods 166:112-119 doi:S1046-2023(18)30330-X [pii] 10.1016/j.ymeth.2019.02.021
Zhavoronkov A et al. (2020) Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. ChemRxiv Preprint doi:https://doi.org/10.26434/chemrxiv.11829102.v2.
Zhavoronkov A et al. (2019) Deep learning enables rapid identification of potent DDR1 kinase inhibitors Nat Biotechnol 37:1038-1040 doi:10.1038/s41587-019-0224-x 10.1038/s41587-019-0224-x [pii]
Zheng W, Li Y, Zhang C, Pearce R, Mortuza SM, Zhang Y (2019) Deep-learning contact-map guided protein structure prediction in CASP13 Proteins 87:1149-1164 doi:10.1002/prot.25792
Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F (2020a) Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Cell Discov 6:14 doi:10.1038/s41421-020-0153-3 153 [pii]
Zhou Y, Wang F, Tang J, Nussinov R, Cheng F (2020b) Artificial intelligence in COVID-19 drug repurposing Lancet Digit Health doi:10.1016/S2589-7500(20)30192-8 S2589-7500(20)30192-8 [pii]
Zhu H (2020) Big Data and Artificial Intelligence Modeling for Drug Discovery Annu Rev Pharmacol Toxicol 60:573-589 doi:10.1146/annurev-pharmtox-010919-023324